Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis
NCT ID: NCT02920411
Last Updated: 2019-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2016-10-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic Dermatitis
NCT02716181
Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)
NCT01781663
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NCT06756438
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combined dermatological treatment
A combined treatment of two emollient products will be applied:
* Pediatopic treatment cream during acute stages of atopic dermatitis and
* Pediatopic body lotion during stable stages
Pediatopic Treatment Cream
Applied twice a day minimum.
Pediatopic Body lotion
Applied at libitum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pediatopic Treatment Cream
Applied twice a day minimum.
Pediatopic Body lotion
Applied at libitum.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with atopic dermatitis mild-moderate with an SCORAD=16-40
Exclusion Criteria
* Corticoids use during 3 weeks prior to the study
* Antibiotics use to treat atopic dermatitis during 3 weeks prior to the study
* Use of topical immunomodulators
* Concurrent use of other emollients
1 Month
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clever Instruments S.L.
INDUSTRY
Laboratorios Ordesa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sapena Jordi, MD
Role: PRINCIPAL_INVESTIGATOR
Centro Médico Quirón Teknon
M.Carmen Gavilan, MD
Role: PRINCIPAL_INVESTIGATOR
Centro Digest Pediatric Badalona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Medic Digest
Badalona, Barcelona, Spain
Centro médico Quirón Teknon
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KAOS-02-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.